JP2013534911A5 - - Google Patents

Download PDF

Info

Publication number
JP2013534911A5
JP2013534911A5 JP2013512927A JP2013512927A JP2013534911A5 JP 2013534911 A5 JP2013534911 A5 JP 2013534911A5 JP 2013512927 A JP2013512927 A JP 2013512927A JP 2013512927 A JP2013512927 A JP 2013512927A JP 2013534911 A5 JP2013534911 A5 JP 2013534911A5
Authority
JP
Japan
Prior art keywords
pyrrolidine
compound
formula
radioactive tracer
och
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013512927A
Other languages
English (en)
Japanese (ja)
Other versions
JP5851493B2 (ja
JP2013534911A (ja
Filing date
Publication date
Priority claimed from EP10164663A external-priority patent/EP2394668A1/en
Application filed filed Critical
Publication of JP2013534911A publication Critical patent/JP2013534911A/ja
Publication of JP2013534911A5 publication Critical patent/JP2013534911A5/ja
Application granted granted Critical
Publication of JP5851493B2 publication Critical patent/JP5851493B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013512927A 2010-06-01 2011-06-01 原発性高アルドステロン症の両側性状態と片側性状態との鑑別診断のためのpet放射性医薬 Expired - Fee Related JP5851493B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10164663A EP2394668A1 (en) 2010-06-01 2010-06-01 PET radiopharmaceuticals for differential diagnosis between bilateral and unilateral conditions of primary hyperaldosteronism
EP10164663.6 2010-06-01
PCT/EP2011/059135 WO2011151411A1 (en) 2010-06-01 2011-06-01 Pet radiopharmaceuticals for differential diagnosis between bilateral and unilateral conditions of primary hyperaldosteronism

Publications (3)

Publication Number Publication Date
JP2013534911A JP2013534911A (ja) 2013-09-09
JP2013534911A5 true JP2013534911A5 (enExample) 2014-09-04
JP5851493B2 JP5851493B2 (ja) 2016-02-03

Family

ID=42668720

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013512927A Expired - Fee Related JP5851493B2 (ja) 2010-06-01 2011-06-01 原発性高アルドステロン症の両側性状態と片側性状態との鑑別診断のためのpet放射性医薬

Country Status (4)

Country Link
US (1) US20130089502A1 (enExample)
EP (2) EP2394668A1 (enExample)
JP (1) JP5851493B2 (enExample)
WO (1) WO2011151411A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013151876A1 (en) * 2012-04-04 2013-10-10 Merck Sharp & Dohme Corp. Aldosterone synthase inhibitors
JP6048958B2 (ja) * 2012-12-27 2016-12-21 日本メジフィジックス株式会社 副腎疾患の画像診断剤
JP2015193545A (ja) * 2014-03-31 2015-11-05 国立大学法人京都大学 2−(3−ピリジニル)−1h−ベンズイミダゾール誘導体化合物、これを含む放射性医薬
ES2821273T3 (es) * 2014-06-26 2021-04-23 Nihon Mediphysics Co Ltd Compuesto derivado de 2-(3-piridinil)-1H-bencimidazol y medicamento que lo contiene
WO2017213247A1 (ja) 2016-06-10 2017-12-14 日本メジフィジックス株式会社 心疾患の非侵襲的画像診断剤
EP3357910A1 (en) * 2017-02-02 2018-08-08 Julius-Maximilians-Universität Würzburg Compound for in vivo diagnosis of a dysfunction of adrenal glands
CN111527079B (zh) 2017-12-28 2023-08-11 日本医事物理股份有限公司 2-[5-(咪唑-1-基甲基)吡啶-3-基]苯并咪唑衍生物化合物及包含其的药物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9271963B2 (en) * 2005-03-03 2016-03-01 Universitat Des Saarlandes Selective inhibitors of human corticosteroid synthases
EP2604290A3 (en) * 2006-05-02 2013-07-10 The Trustees of The University of Pennsylvania Radiolabeled dihydrotetrabenazine derivatives and their use as imaging agents
CN102712589B (zh) * 2009-11-17 2015-05-13 诺华股份有限公司 作为醛固酮合酶抑制剂的芳基-吡啶衍生物

Similar Documents

Publication Publication Date Title
JP2013534911A5 (enExample)
MY170520A (en) Method of synthesizing thyroid hormone analogs and polymorphs thereof
JP2013047277A5 (enExample)
RU2014110400A (ru) Способ и промежуточные соединения для получения макролактамов
WO2016058467A1 (zh) 磷酸泰地唑胺的制备方法
JP2015227339A5 (enExample)
JP2015509939A5 (enExample)
JP2017521398A5 (enExample)
NZ600791A (en) Solid phase extraction purification technique
RU2020114951A (ru) Термопластичныe полиоксазолидоны из диизоцианатов и производных диглицидилового эфира 2-фенил-1,3-пропандиола
CN105669760A (zh) 一种有机磷杂菲衍生物及其制备方法与应用
JP2011116782A5 (enExample)
CN104447755B (zh) 一种六氢吡咯[2,3-b]吲哚羧酸酯化合物及其合成方法
RU2018104555A (ru) Новое соединение, специфически связывающееся с рецептором ampa
JP2018009003A5 (enExample)
JP2013189391A5 (enExample)
JP2017532329A5 (enExample)
CN104926868A (zh) 一种制备吲哚膦酸酯衍生物的方法
JP6085884B2 (ja) ビナフトール骨格を有するビスアミノイミン配位子及び触媒
JP2016516809A5 (enExample)
JP2016533390A (ja) 放射ヨウ素標識された3−フルオロプロピル−NOR−β−CITの調製
RU2015135184A (ru) Способ получения соединения пиридазинона и промежуточных продуктов для его получения
CN105384715B (zh) 一种7-位取代的3-溴-4-苯基香豆素系列化合物制备方法
JP2014132089A5 (enExample)
CN104804039A (zh) 有机磷系阻燃剂代谢物的合成方法